SENTRYBOND

DEAD

Serial Number

90664074

Owner

OHEMO LIFE SCIENCES INC.

Attorney

William E. Beaumont

Filing Date

Apr 22, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

SENTRYBOND Trademark

Serial Number: 90664074

SENTRYBOND is a trademark filed by OHEMO LIFE SCIENCES INC. on April 22, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

OHEMO LIFE SCIENCES INC. (22 trademarks)

CARR. 198 KM 14.7 # 100
JUNCOS, PR 007773873

Entity Type: 03

Legal Representation

Attorney of Record

William E. Beaumont

34 trademarks filed View all →

Correspondence Address

William E. Beaumont JUNEAU & MITCHELL PLLC

1727 KING ST.

SUITE 300

ALEXANDRIA, VA 22314

United States

Trademark Details

Filing Date

April 22, 2021

Registration Date

Not Registered

Published for Opposition

January 25, 2022

Goods & Services

Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Oct 10, 2025 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Oct 10, 2025 ABN6

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 3, 2024 EXRA

SOU EXTENSION 5 GRANTED

Sep 3, 2024 EX5G

SOU EXTENSION 5 FILED

Sep 3, 2024 EXT5

SOU TEAS EXTENSION RECEIVED

Sep 3, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 8, 2024 EXRA

SOU EXTENSION 4 GRANTED

Mar 7, 2024 EX4G

SOU EXTENSION 4 FILED

Mar 7, 2024 EXT4

SOU TEAS EXTENSION RECEIVED

Mar 7, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 13, 2023 EXRA

SOU EXTENSION 3 GRANTED

Sep 11, 2023 EX3G

SOU EXTENSION 3 FILED

Sep 11, 2023 EXT3

SOU TEAS EXTENSION RECEIVED

Sep 11, 2023 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 29, 2023 EXRA

SOU EXTENSION 2 GRANTED

Mar 28, 2023 EX2G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Mar 27, 2023 AITU

SOU EXTENSION 2 FILED

Mar 15, 2023 EXT2

SOU TEAS EXTENSION RECEIVED

Mar 15, 2023 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 24, 2022 EXRA

SOU EXTENSION 1 GRANTED

Sep 22, 2022 EX1G

SOU EXTENSION 1 FILED

Sep 22, 2022 EXT1

SOU TEAS EXTENSION RECEIVED

Sep 22, 2022 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 22, 2022 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 25, 2022 NPUB

PUBLISHED FOR OPPOSITION

Jan 25, 2022 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 5, 2022 NONP

LAW OFFICE PUBLICATION REVIEW COMPLETED

Dec 21, 2021 PREV

ASSIGNED TO LIE

Dec 21, 2021 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 21, 2021 CNSA

ASSIGNED TO EXAMINER

Dec 16, 2021 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 29, 2021 NWOS

NEW APPLICATION ENTERED

Apr 26, 2021 NWAP

Related Trademarks

More from this Owner

MORPHABOND · ER (MORPHINE SULFATE) EXTENDED - RELEASE TABLETS

MORPHABOND ER

ROXYBOND

MORPHABOND · ER (MORPHINE SULFATE) EXTENDED-RELEASE TABLETS

ROXYBOND

More in Same Class